Larson Financial Group »

Revance Therapeutics shares owned by Larson Financial Group

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Larson Financial Group from 13F filings

Historical chart of Larson Financial Group investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Larson Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Larson Financial Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $37k 7.1k 5.19
2024-06-30 $18k 7.1k 2.57

More positions owned by Larson Financial Group

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Mid Cap Etf (VO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Eafe Value Etf (EFV)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Core Msci Eafe (IEFA)
American Centy Etf Tr Avantis Emgmkt (AVEM)
NVIDIA Corporation (NVDA)
Spdr Ser Tr Portfolio S&p500 (SPLG)
First Tr Exchng Traded Fd Vi Tcw Opportunis (FIXD)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
First Tr Value Line Divid In SHS (FVD)
Vanguard Index Fds Sml Cp Grw Etf (VBK)
First Tr Exchng Traded Fd Vi Tcw Unconstrai (UCON)
Dimensional Etf Trust Us Targeted Vlu (DFAT)

View all positions for Larson Financial Group

Top funds holding Revance Therapeutics

BlackRock
BlackRock
Vanguard Group
Franklin Resources
Alpine Associates Management
Magnetar Financial
Tang Capital Management
Geode Capital Management
State Street Corporation
LMR Partners
D. E. Shaw & Co
Omni Event Management
Palo Alto Investors
CNH Partners
Gabelli Funds

View all funds holding Revance Therapeutics